MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas.
about
microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and ChallengesTGF-β/Smad2/3 signaling directly regulates several miRNAs in mouse ES cells and early embryosA survey of small RNAs in human spermIntegrative analysis of neuroblastoma and pheochromocytoma genomics data.Noncoding RNAs in endocrine malignancyIdentification of serum miR-139-3p as a non-invasive biomarker for colorectal cancer.Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue.Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentMultiple tumor suppressor microRNAs regulate telomerase and TCF7, an important transcriptional regulator of the Wnt pathwayMulti-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.Discovery of shear- and side-specific mRNAs and miRNAs in human aortic valvular endothelial cells.Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression.The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma.Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomasIntegrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway.Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.An emerging role for microRNAs in NF1 tumorigenesis.MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy.Rethinking pheochromocytomas and paragangliomas from a genomic perspective.The role of miRNAs in the pheochromocytomas.Potential role of miR-139-5p in cancer diagnosis, prognosis and therapyMir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.Identification of miRNAs as potential new biomarkers for nervous system cancer.Identification of differentially expressed microRNAs in acute Kawasaki disease.Extensive miRNA expression analysis in craniopharyngiomas.miR-375 negatively regulates the synthesis and secretion of catecholamines by targeting Sp1 in rat adrenal medulla.[New aspects of tumor pathology of the adrenal glands].
P2860
Q26772746-7A216598-D3DC-4B50-9F55-3EF61209F92AQ28593016-3B06142C-11F9-43D9-8EFB-80B4A403FF00Q28742953-07B1A26C-306B-45AA-B1F0-3FAE33B7FD98Q30575178-1E5D758A-668C-4E68-807C-22DF440947D8Q33577889-63A4CED3-555D-451B-B458-34361540820AQ33689057-BCE9F9E5-B506-45C4-A33F-AD86F5D66278Q34216309-E9677A33-D754-4D5F-91E6-147B5ADE5ED3Q34410500-05BF27CC-0D47-40AE-88A1-A7227BB182A7Q35097232-4B88AAAD-81D4-49DD-A04B-71FCB9647AA6Q35160825-AC2F9698-D416-44BC-9B25-0340DA01CBACQ35315207-073CEDDF-3069-429B-B61B-5784DF17A746Q36032827-C1F11C5C-DFA5-4033-B7C5-E73D26BE1B12Q36473314-E70E191F-E123-4528-939B-83C0BAC885CAQ36804496-6307D80F-CD48-4064-8396-941BF88EDB13Q37213634-356E484E-74BC-497A-8282-A386A8E69323Q37688892-252AD1BA-069C-41CC-B519-EF7AED0E61AEQ37969708-EE805A74-D803-46D8-AAFE-02B0AC06F194Q38060281-056C09EB-3E8E-4A44-85BB-2D038DD21892Q38258284-F91854E4-13C0-43E2-B3A7-F6B6D6359F7CQ38509463-37514F72-366F-45CB-9211-9F52954829B4Q38606234-B6503C8B-4858-4B6D-966B-CE5491E7041FQ38645381-641250AB-51C6-46B0-9338-06922AE2864EQ38779492-33659109-42F7-46FE-8916-DB7601C1D476Q48303148-9F194D09-15C8-418B-A537-22DB360D33AAQ48595509-F7880C90-BF46-41E5-9700-EBEF3F9C1F48Q49188517-B4CEB3B8-682B-4BEA-8DB2-D3E501ECF248Q50506331-F00C15C8-5E87-4F2D-892B-EC292A259447Q51081683-C49D329F-B100-48F5-9E69-F9E4790F8CE9Q53519234-4E5FB07F-8BEF-4B2E-91B6-C18F1185EEAD
P2860
MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
MicroRNA expression profiling ...... ing adrenal pheochromocytomas.
@ast
MicroRNA expression profiling ...... ing adrenal pheochromocytomas.
@en
MicroRNA expression profiling in benign
@nl
type
label
MicroRNA expression profiling ...... ing adrenal pheochromocytomas.
@ast
MicroRNA expression profiling ...... ing adrenal pheochromocytomas.
@en
MicroRNA expression profiling in benign
@nl
prefLabel
MicroRNA expression profiling ...... ing adrenal pheochromocytomas.
@ast
MicroRNA expression profiling ...... ing adrenal pheochromocytomas.
@en
MicroRNA expression profiling in benign
@nl
P2093
P2860
P50
P1433
P1476
MicroRNA expression profiling ...... ring adrenal pheochromocytomas
@en
P2093
Attila Kovács
Attila Patócs
Attila Zalatnai
Gergely Rácz
István Likó
Katalin Eder
Károly Rácz
Miklós Tóth
Peter M Szabó
Zsófia Tömböl
P2860
P2888
P304
P356
10.1038/MODPATHOL.2010.164
P577
2010-09-03T00:00:00Z
P5875
P6179
1035586894